Veeva Systems (VEE) AI Stock Analysis

0 Followers

Veeva Systems

(BX Swiss:VEE)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

High profitability and cash conversionVeeva converts its subscription-oriented software model into strong profitability, with high gross and net margins supported by recurring customer revenue. Cash flow closely tracks earnings, giving the company durable capacity to fund product development, strategic investments, and growth without relying heavily on external capital.

Negative Factors

Material revenue growth decelerationThe sharp slowdown in revenue growth indicates that Veeva is operating from a more mature base and faces a tougher path to reacceleration. Even with strong margins, slower expansion can limit operating leverage, reduce the pace of market penetration, and increase dependence on successful new products.

Veeva Systems (VEE) vs. iShares MSCI Switzerland ETF (EWL)

Market Cap: CHF 49.35B
Dividend Yield: ―
Average Volume (3M): 11
Price to Earnings (P/E): 49.1
Beta (1Y): -0.05
Revenue Growth: 7.76%
EPS Growth: 15.14%
Country: Switzerland
Employees: 7,928
Sector: Healthcare
Sector Strength: 51
Industry: Software - Application

Veeva Systems Business Overview & Revenue Model

Company Description

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, A...

Veeva Systems Earnings Call Summary

Earnings Call Date:Aug 26, 2026(Q2-2027)|% Change Since:30.28%|Next Earnings Date:Nov 26, 2026

Earnings Call SentimentPositive

The call communicated a predominantly positive operational and financial performance: revenue of $928M, non-GAAP operating income of $416M (~44.8% margin), strong commercial subscription growth (~13% YoY), record CRM results, and meaningful early traction in AI (Falcon) and Data Cloud. Management raised guidance and highlighted selective, disciplined investments (Aspen) and a healthy IQVIA partnership. Key risks centered on execution and timing for agentic AI (product readiness, onboarding capacity, pricing models), potential model-compute cost pressure, and staggered timing of R&D product ramps. Overall, highlights (strong revenue/profitability, CRM wins, AI interest, Data Cloud additions, guidance raise) materially outweigh the manageable near-term execution and timing lowlights.

Positive Updates

Strong Quarter — Revenue and Profitability

Total revenue of $928 million and non-GAAP operating income of $416 million in Q2 FY2027, implying a non-GAAP operating margin of ~44.8%, with results coming in ahead of guidance.

Negative Updates

Falcon — Early-Stage Risks and Capacity Constraints

Falcon is promising but early: Veeva describes itself as the 'rate limiter' — constrained product readiness and onboarding capacity for early adopters could limit near-term monetization and require careful execution of human-in-loop, training and regulatory guardrails.

Company Guidance

Management said it has raised and updated FY‑2027 guidance (with no material incremental investments for the fiscal year beyond what is already factored in), while reporting Q2 results of $928 million total revenue and $416 million non‑GAAP operating income; Commercial subscriptions were up about 13% year‑over‑year (double‑digit ex‑Crossix), Crossix remains a strong performer, Data Cloud added 14 customers, and Veeva has over 180 CRM customers live. They noted five Falcon early adopters with first go‑lives expected this year, described Aspen as a small, 90‑day‑paced investment not yet included in revenue plans, and said they will scale sales/R&D spend with revenue and revisit guidance for the next fiscal year after a few more quarters (while watching CRM win‑backs and product rollouts into 2027–2029).

Veeva Systems Risk Analysis

Veeva Systems disclosed 43 risk factors in its most recent earnings report. Veeva Systems reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Veeva Systems Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

CH:VEE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DOCU	82Outperform	$14.51B	47.99	17.74%	―	8.59%	20.88%
ROP	82Outperform	$46.99B	18.88	13.53%	0.76%	9.24%	73.95%
PTC	76Outperform	$21.35B	22.11	28.34%	―	-0.21%	43.61%
TEAM	63Neutral	$37.43B	435.54	8.00%	―	26.59%	―
WK	62Neutral	$3.64B	61.74	-157.37%	―	18.80%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

CH:VEE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CH:VEE	Veeva Systems Inc	259.41	134.61	107.86%
ROP	Roper Technologies	477.70	32.50	7.30%
PTC	PTC Inc.	196.14	16.53	9.20%
WK	Workiva Inc.	69.77	-21.26	-23.35%
TEAM	Atlassian Corporation Plc	152.44	0.65	0.43%
DOCU	Docusign	80.15	12.39	18.29%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Veeva Systems AI Stock Analysis